Adults with obesity but without type 2 diabetes received either the maximum tolerated dose of tirzepatide or the maximum tolerated dose of semaglutide
In the STEP 1 trial, approximately 44% of participants in the Wegovy group reported nausea at some point during treatment
The Four-Week Titration Schedule and Beyond After your initial four weeks at the entry dose, semaglutide dosing continues to increase in 0.25 mg increments every four weeks until reaching your therapeutic dose
The single dose, short (1 h) observation period, and lack of placebo arm are limitations in this proof-of-concept study and provide direction for follow-up studies
As of the time of writing, retatrutide has not received marketing authorisation from the MHRA, the EMA, or the US Food and Drug Administration (FDA)
Molecular studies on the mechanisms of action of antipsychotics and antidepressants, and of hypoglycemic drugs used for metabolic disorders, are beginning to show that some key enzymes can regulate aspects of both energy management and psychopathology